Amygdala deep brain stimulation is superior to paroxetine treatment in a rat model of posttraumatic stress disorder

Author(s): Stidd DA, Vogelsang K, Krahl SE, Langevin JP, Fellous JM, et al.

Abstract

Background

Posttraumatic stress disorder (PTSD) is a very debilitating disease refractory to current treatment with selective serotonin reuptake inhibitors (SSRIs) in up to 30 percent of patients, illustrating the need for new treatments of PTSD. Neuroimaging studies have shown increased activity of the amygdala of patients with PTSD.

Objective/hypothesis

To investigate amygdala deep brain stimulation (DBS) as a possible novel treatment for PTSD and compare it to current treatment with a commonly used SSRI, paroxetine, in a rat PTSD model.

Methods

A PTSD model was created by subjecting rats to inescapable foot shocks in the presence of a conspicuous ball. Response to treatment was measured as a decreased burying behavior when presented with the same ball 1 and 2 weeks after the shocks. Rats were treated with either daily intraperitoneal paroxetine injections or amygdala DBS via an electrode implanted 1 week prior to shocks. Generalized anxiety was assessed using an elevated plus maze.

Similar Articles

The structure of PTSD symptoms according to DSM-5 and IDC-11 proposal: A multi-sample analysis

Author(s): Cyniak Cieciura M, Staniaszek K, Popiel A, Praglowska E, Zawadzki B, et al.

Pharmacology for sleep disturbance in PTSD

Author(s): Lipinska G, Baldwin DS, Thomas KG

PTSD symptoms, demographic characteristics, and functional status among veterans treated in VA primary care clinics

Author(s): Magruder KM, Frueh BC, Knapp RG, Johnson MR, Vaughan JA, et al.

The effect of draft DSM-V criteria on posttraumatic stress disorder prevalence

Author(s): Calhoun PS, Hertzberg JS, Kirby AC, Dennis MF, Hair LP, et al.

National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria

Author(s): Kilpatrick DG, Resnick HS, Milanak ME, Miller MW, Keyes KM, et al.

Gender differences in substance abuse, PTSD and intentional self-harm among veterans health administration patients

Author(s): Gradus JL, Leatherman S, Curreri A, Myers LG, Ferguson R, et al.

Mild traumatic brain injury in U

Author(s): Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, et al.

Blast-related traumatic brain injury

Author(s): Rosenfeld JV, McFarlane AC, Bragge P, Armonda RA, Grimes JB, et al.

Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder

Author(s): Yehuda R, Giller EL, Southwick SM, Lowy MT, Mason JW, et al.

Neurobiology of posttraumatic stress disorder

Author(s): Heim C, Nemeroff CB

A users guide to HPA axis research

Author(s): Spencer RL, Deak T

PTSD and gene variants new pathways and new thinking

Author(s): Skelton K, Ressler KJ, Norrholm SD, Jovanovic T, Bradley Davino B, et al.

  Glucocorticoid receptor polymorphisms and post-traumatic stress disorder

Author(s): Bachmann AW, Sedgley TL, Jackson RV, Gibson JN, Young RM, et al.

Association of CRHR1 variants and posttraumatic stress symptoms in hurricane exposed adults

Author(s): White S, Acierno R, Ruggiero KJ, Koenen KC, Kilpatrick DG,  et al.

Increased CSF cortisol in AD is a function of APOE genotype

Author(s): Peskind ER, Wilkinson CW, Petrie EC, Schellenberg GD, Raskind MA, et al.

Effect Of The APOE epsilon4 Allele And Combat Exposure On PTSD Among Iraq/Afghanistan-Era Veterans

Author(s): Kimbrel NA, Hauser MA, Garrett M, Ashley Koch A, Liu Y, et al.

Variant in RGS2 moderates posttraumatic stress symptoms following potentially traumatic event exposure

Author(s): Amstadter AB, Koenen KC, Ruggiero KJ, Acierno R, Galea S, et al.

The ankyrin-3 gene is associated with posttraumatic stress disorder and externalizing comorbidity

Author(s): Logue MW, Solovieff N, Leussis MP, Wolf EJ, Melista E, et al.

The DRD2 gene 957C>T polymorphism is associated with posttraumatic stress disorder in war veterans

Author(s): Voisey J, Swagell CD, Hughes IP, Morris CP, van Daal A, et al.

Glucocorticoid receptors in depression relationship to the dexamethasone suppression test

Author(s): Gormley GJ, Lowy MT, Reder AT, Hospelhorn VD, Antel JP, et al.

Glucocorticoid receptors and depression

Author(s): Whalley LJ, Borthwick N, Copolov D, Dick H, Christie JE,  et al.

Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder

Author(s): Yehuda R, Kahana B, Binder Brynes K, Southwick SM, Mason JW,  et al.

Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis

Author(s): Johnson EO, Kamilaris TC, Chrousos GP, Gold PW

Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder

Author(s): Kosten TR, Mason JW, Giller EL, Ostroff RB, Harkness L, et al.

Noradrenergic dysregulation in the pathophysiology of PTSD

Author(s): Hendrickson RC, Raskind MA

The neurobiology of PTSD implications for nurses

Author(s): Olszewski TM, Varrasse JF

The cardiovascular toll of stress

Author(s): Brotman DJ, Golden SH, Wittstein IS

Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder

Author(s): Von Kanel R, Hepp U, Kraemer B, Traber R, Keel M, et al.

PTSD NCf Overview of Psychotherapy for PTSD

Author(s): Norman S, Hamblen J, Paula P. Schnurr, Eftekhari A, et al.

Review of exposure therapy: a gold standard for PTSD treatment

Author(s): Rauch SA, Eftekhari A, Ruzek JI

PTSD and TBI co-morbidity: scope, clinical presentation and treatment options

Author(s): Tanev KS, Pentel KZ, Kredlow MA, Charney ME

Classical fear conditioning in the anxiety disorders: a meta-analysis

Author(s): Lissek S, Powers AS, McClure EB, Phelps EA, Woldehawariat G, et al.

Deep brain stimulation: indications and evidence

Author(s): Pereira EA, Green AL, Nandi D, Aziz TZ

MRI uncovers disrupted hippocampal microstructure that underlies memory impairments after early-life adversity

Author(s): Molet J, Maras PM, Kinney Lang E, Harris NG, Rashid F, et al.

MicroRNAs in Post-traumatic Stress Disorder

Author(s): Snijders C, de Nijs L, Baker DG, Hauger RL, van den Hove D, et al.

DICER1 and microRNA regulation in post-traumatic stress disorder with comorbid depression

Author(s): Wingo AP, Almli LM, Stevens JS, Klengel T, Uddin M, et al.

Hyperbaric oxygen therapy in the battlefield

Author(s): Verghese G, Verma R, Bhutani S